SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3C.L Regulatory News (K3C)

  • There is currently no data for K3C

Scheme effective

14 Feb 2023 09:20

RNS Number : 8726P
K3 Capital Group PLC
14 February 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

FOR IMMEDIATE RELEASE

 

14 February 2023

 

RECOMMENDED CASH ACQUISITION

OF

K3 CAPITAL GROUP PLC ("K3")

BY

SHIN BIDCO LIMITED ("BIDCO")

a company controlled by affiliates of

Sun European Partners, LLP

Scheme effective

Further to the announcement made by K3 on 10 February 2023 that the Court had sanctioned the Scheme, K3 and Bidco are pleased to announce that, following the delivery of a copy of the Scheme Court Order to the Registrar of Companies earlier today, the Scheme has now become Effective, and accordingly Bidco is now the owner of all Scheme Shares.

 

Settlement

 

Scheme Shareholders on the register at the Scheme Record Time, being 6.00 p.m. on 13 February 2023, will receive 350 pence in cash for each Scheme Share.

 

The latest date for the despatch of cheques to Scheme Shareholders and settlement through CREST for cash consideration due under the terms of the Scheme is 28 February 2023.

 

As a result of the Scheme having become effective, share certificates in respect of K3 Shares have ceased to be valid evidence of title and entitlements to K3 Shares held in uncertificated form in CREST have been cancelled.

 

Suspension and cancellation of admission to trading on AIM

 

The K3 Shares were suspended from trading on AIM with effect from 7.30 a.m. today. An application has been made to the London Stock Exchange for the cancellation of the admission to trading of K3 Shares on AIM, which is expected to take effect at 7.00 a.m. on 15 February 2023.

 

Director resignations

 

As envisaged in the Scheme Document, each of the Independent K3 Directors has resigned as a director of K3 with effect from the Scheme becoming Effective.

 

Other

All references to times in this announcement are to London time.

Capitalised terms used in this announcement shall, unless otherwise defined, have the meanings set out in Part IX of the Scheme Document dated 5 January 2023.

Shareholder Helpline

If you are a K3 Shareholder and you have any questions relating to this announcement, please contact Computershare Investor Services PLC on 0370 707 1431 (from within the UK) or on +44 (0) 370 707 1431 (from outside the UK) between 8.30 a.m. and 5.30 p.m. Monday to Friday (excluding public holidays). Please note that calls to these numbers may be monitored or recorded and that, for legal reasons, the helpline cannot provide advice on the merits of the Acquisition or give any legal, tax or financial advice.

 

Enquiries

K3

Via Alma

Ian Mattioli, Non-Executive Chairman of K3

John Rigby, Chief Executive Officer

Andrew Melbourne, Chief Financial Officer

Numis (Financial adviser, nominated adviser and corporate broker to K3)

+44 20 7260 1000

Stuart Skinner

Stuart Ord

William Wickham

Tom Burrows Smith

Charlie George

Alma PR (Financial PR adviser to K3)

+44 20 3405 0205

Josh Royston

Hilary Buchanan

Sam Modlin

Sun European Partners, LLP

+44 20 7318 1100

Paul Daccus

Alexander Wyndham

Houlihan Lokey UK Limited(Financial adviser to Sun and Bidco)

+44 20 7839 3355

Tim Richardson

William Marshall

Jon Harrison

Oliver Vaughan

Kevin Rogstad

Camarco (Financial PR adviser to Sun and Bidco)

+44 20 3757 4980

Jennifer Renwick

Julia Tilley

 

Weil, Gotshal & Manges (London) LLP is providing legal advice to Bidco and Sun.

Addleshaw Goddard LLP is providing legal advice to K3.

Important notices

Houlihan Lokey UK Limited ("Houlihan Lokey"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as financial adviser exclusively for Sun and Bidco and for no one else in connection with the matters described in this announcement and will not be responsible to anyone other than Sun and Bidco for providing the protections afforded to its clients or for providing advice in relation to such matters. Neither Houlihan Lokey nor any of its affiliates (nor any of their respective directors, officers, employees or agents), owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Houlihan Lokey in connection with this announcement, any statement contained herein or otherwise.

Numis Securities Limited ("Numis"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as financial adviser, nominated adviser and corporate broker exclusively for K3 and no one else in connection with the matters set out in this announcement and will not be responsible to anyone other than K3 for providing the protections afforded to clients of Numis, nor for providing advice in relation to any matter referred to herein. Neither Numis nor any of its affiliates (nor any of their respective directors, officers, employees or agents), owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Numis in connection with this announcement, any statement contained herein or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SOAGCGDDCBBDGXS
Date   Source Headline
28th Mar 20227:00 amRNSChange of Adviser
7th Mar 20222:10 pmRNSDirector/PDMR Shareholding
1st Mar 20227:00 amRNSAcquisition of JE Consulting
22nd Feb 20225:28 pmRNSIssue of Equity
7th Feb 20227:00 amRNSHalf-year Report
27th Jan 20227:00 amRNSNotice of Results and Investor Presentation
13th Dec 20217:00 amRNSTrading Update
7th Dec 202110:21 amRNSDirector/PDMR Shareholding
6th Dec 202111:15 amRNSDirector/PDMR Shareholding
2nd Dec 20217:00 amRNSDirector/PDMR Shareholding
25th Nov 202112:00 pmRNSResult of AGM
23rd Nov 20217:00 amRNSK3 to present at Mello
2nd Nov 202111:42 amRNSIssue of Equity
1st Nov 20212:05 pmRNSNotice of AGM & Dividend Timetable
1st Nov 20217:00 amRNSFinal Results and Notice of AGM
19th Oct 20217:00 amRNSInvestor Presentation
15th Oct 20217:00 amRNSNotice of Results
7th Sep 20214:17 pmRNSHolding(s) in Company
1st Sep 20217:00 amRNSIssue of Equity
7th Jul 202110:55 amRNSResult of Fundraising
7th Jul 20217:00 amRNSProposed Acquisitions and Placing to Raise £10m
21st Jun 202110:57 amRNSIssue of Equity
15th Jun 20217:00 amRNSTrading Update
24th May 20217:00 amRNSMaiden Debt Facility
5th May 20218:30 amRNSIssue of Equity
16th Apr 20217:00 amRNSIssue of Equity
14th Apr 20217:00 amRNSTrading Update
7th Apr 20214:04 pmRNSHolding(s) in Company
1st Apr 20217:00 amRNSTotal Voting Rights
31st Mar 20218:00 amRNSDirector/PDMR Shareholding
17th Mar 20217:00 amRNSDirector/PDMR Shareholding & Exercise of Options
4th Mar 20217:00 amRNSTrading Update
16th Feb 20213:15 pmRNSHolding(s) in Company
16th Feb 20217:00 amRNSHalf-year Report
3rd Feb 20217:00 amRNSNotice of Results and Investor Presentation
15th Jan 202112:00 pmRNSDirector/PDMR Shareholding
15th Dec 20209:05 amRNSSecond Price Monitoring Extn
15th Dec 20209:00 amRNSPrice Monitoring Extension
15th Dec 20207:00 amRNSAppointment of Joint Broker
15th Dec 20207:00 amRNSTrading Update
30th Nov 20207:00 amRNSJoint Venture Agreement
17th Nov 20207:00 amRNSAward of Growth Shares
13th Nov 20209:05 amRNSSecond Price Monitoring Extn
13th Nov 20209:00 amRNSPrice Monitoring Extension
9th Nov 20207:00 amRNSCompletion of Integration Plan
3rd Nov 20202:00 pmRNSLaunch of 2020 SAYE Scheme
16th Oct 202011:30 amRNSResult of AGM
7th Oct 202012:30 pmRNSStatement re change of AGM arrangements
23rd Sep 20201:12 pmRNSDirector/PDMR Shareholding
22nd Sep 20207:00 amRNSFinal Results and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.